IntuitionLabs
TrackWise Digital AI integration services with MCP adapters and LLM agents for pharma quality

TrackWise AI Integration — MCP & LLM Agents for Quality Operations

Connect Claude, GPT, and other modern AI agents to TrackWise Digital and classic TrackWise with custom MCP adapters and the Salesforce API surface. Deviation triage, CAPA analytics, and audit readiness — validated for GxP production use.

Our TrackWise AI Integration Services

We build validated AI workflows on top of TrackWise Digital and classic TrackWise. From MCP adapter architecture through GAMP 5 validation, we deliver production-grade AI for pharmaceutical and medical device quality operations.

MCP Architecture
Custom MCP Adapters
We build Model Context Protocol adapters in front of the Salesforce API surface so LLM agents can query deviations, CAPAs, change controls, and audits safely — with inherited permissions, read-only guardrails, and audit logging.
Discuss MCP architecture
AI Workflows
Deviation & CAPA Intelligence
Deviation triage, CAPA effectiveness analytics, root cause pattern detection, and cross-site trending — all delivered as validated AI workflows on top of your TrackWise Digital data with human-in-the-loop approval.
See AI use cases
Validation
GAMP 5 AI Validation
We validate AI agents under GAMP 5 Second Edition with risk-based classification, intended-use specifications, output-validation test cases, and continuous monitoring — so your AI layer passes inspection alongside TrackWise itself.
View validation approach

Built on the Salesforce API Surface

TrackWise Digital runs on the Salesforce Platform, which exposes an exceptionally rich integration surface — the Salesforce REST API, Bulk API 2.0, Streaming API, GraphQL API, Platform Events, and Change Data Capture. We use this API surface to build Model Context Protocol adapters that let modern LLM agents like Claude Opus query TrackWise data safely. The adapter enforces role-based access, exposes a curated read-only tool surface, and logs every query in a tamper-evident audit trail.

TrackWise Digital AI architecture built on the Salesforce Platform API surface

Human-in-the-Loop by Design

Our default architecture is read-only and human-approved. AI agents draft and cite — they do not close deviations, approve CAPAs, or sign change controls. Every action of record is performed by a human with appropriate authority, which is what 21 CFR Part 11 and MHRA GxP data integrity require. The AI layer reduces investigation cycle time and improves consistency without introducing a new class of regulatory risk.

Human-in-the-loop AI architecture for pharmaceutical quality operations

Cross-System Context, Not a Silo

The most valuable AI workflows combine TrackWise with context from other systems — LIMS for analytical results, MES for process data, SAP for material and batch master, and analytical platforms like Snowflake for cross-site trending. Our MCP-based architecture lets one agent session aggregate context across all of these systems. The result is a quality intelligence layer that operates across the full manufacturing stack, not just the QMS silo.

AI agent aggregating context across TrackWise, LIMS, MES, SAP, and Snowflake for pharma quality analytics

High-Value AI Workflows on TrackWise Digital

Deviation Triage & Drafting

AI reads initial deviation descriptions, suggests risk classifications based on historical patterns, highlights similar open and closed events, and drafts an initial investigation plan — fully cited, human-reviewed, and GxP-validated.

Request a pilot

CAPA Effectiveness Analytics

Cross-site, cross-product CAPA pattern detection surfaces systemic root causes that local investigations miss. AI analytics evaluate effectiveness verification results and flag CAPAs that are treating symptoms rather than root causes.

Discuss use cases

Audit Readiness Assistant

Continuously scans open events, overdue actions, and document review status to produce an audit-ready dashboard. During inspections, pulls records and evidence in seconds for any question from an FDA, EMA, or MHRA investigator.

See audit AI demo

Complaint Triage & MDR Classification

For medical device manufacturers, AI classifies incoming complaints against FDA MDR and EU MDR reportability criteria, highlights serious adverse events for priority handling, and drafts initial intake summaries for human review.

Explore device workflows

Change Control Impact Analysis

AI assesses proposed changes against historical change patterns, ICH Q12 post-approval change categories, and regulatory filing impact — producing a draft impact assessment that cross-functional reviewers refine and approve.

Discuss change AI

Supplier Risk Scoring

AI-enhanced supplier risk scoring combines internal quality event history, audit findings, and external regulatory signals (FDA 483s, warning letters, import alerts) for continuous risk reassessment aligned with ICH Q9 (R1).

See supplier AI

Today's business insights

Profitable growth in the AI solutions industry

Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.

More insights on unlock profitable growth in ai solutions
Profitable growth in the AI solutions industry

Defense-in-Depth Security for GxP AI

AI agents that access GxP data face first-order risks: prompt injection, data leakage, hallucination, and authorization escalation. Our architecture addresses each with specific controls — structured prompt engineering, permission inheritance, output validation against source data, model-level instruction-hierarchy training, and tamper-evident audit logging of every tool call. We align these controls with the NIST AI Risk Management Framework and emerging OWASP LLM Top 10 guidance.

Defense-in-depth security architecture for GxP-validated AI agents accessing TrackWise quality data

Validated Under GAMP 5 Second Edition

Every AI component we deploy is validated under GAMP 5 Second Edition, which explicitly addresses machine learning and AI. We produce intended-use specifications, risk assessments that address AI-specific failure modes (hallucination, drift, prompt injection), a curated validation test set with known-good and adversarial prompts, and continuous monitoring that detects drift in production. The AI layer passes inspection alongside TrackWise itself.

GAMP 5 Second Edition validation methodology for AI agents in pharmaceutical quality systems

Model Choice and Data Residency

We help pharma quality organizations pick the right model for the right workflow. Reasoning-heavy tasks like deviation drafting and CAPA pattern detection are best served by the strongest frontier models (Claude Opus 4.7, GPT-5). Classification and extraction workflows can use smaller, cheaper models. For EU-regulated deployments, we deploy via Anthropic's EU endpoints, Azure OpenAI EU regions, or on-premise inference — whichever meets your data residency requirements under GDPR and internal data classification policies.

Model selection and data residency architecture for regulated AI deployments in pharma quality

Our TrackWise AI Tech Stack

🧠

Anthropic Claude + MCP

Claude Opus via the Model Context Protocol for reasoning-heavy quality workflows — deviation investigation, CAPA pattern detection, and audit readiness.

☁️

Salesforce API + Apex

Salesforce REST, Bulk, Streaming, and GraphQL APIs plus custom Apex for deep TrackWise Digital integration — permission-inheriting, audited, and validated.

🔗

MuleSoft & Integration Suite

Enterprise integration layer for bidirectional flows between TrackWise Digital, SAP S/4HANA, LabWare, and other systems in the pharma manufacturing stack.

📊

Snowflake & Databricks

Analytical data lake for cross-site, cross-product quality trending — with CDC-based extraction from TrackWise and dimensional modeling for AI-ready quality data.

⚙️

Python & Node.js Adapters

Custom MCP server implementations in Python and Node.js that wrap the Salesforce API surface with read-only guardrails, role-based filtering, and audit logging.

🛡️

NIST AI RMF + OWASP LLM

Security and governance frameworks applied to every GxP AI deployment — covering prompt injection, data leakage, hallucination, and continuous monitoring.

Our TrackWise AI Engagement Model

We structure TrackWise AI engagements in three phases that let clients make informed decisions at each stage. Discovery produces a concrete use-case design and validation strategy. Pilot proves value against a TrackWise Digital sandbox. Production rollout scales validated workflows across the broader quality organization.

Discovery & Use-Case Design

Use-case selection, architecture design, validation strategy, and ROI model — typically 4 to 6 weeks.

Pilot & Validation

MCP adapter build, pilot deployment, GAMP 5 validation, and business-value demonstration against sandbox.

Production & Scale

Validated production rollout, expansion to adjacent use cases, and managed services for ongoing AI ops.

Frequently Asked Questions

As of early 2026, Honeywell does not publish an official Model Context Protocol server for TrackWise Digital. However, TrackWise Digital runs on the Salesforce Platform, which exposes an exceptionally rich API surface — the Salesforce REST API, Bulk API 2.0, Streaming API, GraphQL API, Platform Events, and Change Data Capture — plus Apex and Flow for custom logic. IntuitionLabs builds custom MCP adapters in front of that API surface, exposing a curated set of read-only tools (e.g. look up open deviations for a batch, retrieve CAPA effectiveness history, list audit findings by site, search change controls by product) that AI agents like Claude or GPT-based applications can call over the MCP protocol. Because we build the adapter, we can also scope, audit, and validate it precisely — which is essential for GxP use.
We build several production-grade AI workflows that address concrete pharma quality pain points. Deviation triage and drafting lets a quality professional ask the AI to classify a new deviation, highlight similar historical events, and draft an initial investigation plan — citing every source. Cross-site CAPA effectiveness analytics use quality event history to surface patterns that suggest systemic rather than local root causes. Audit readiness assistants continuously scan open events, overdue actions, and document status to produce an audit-ready dashboard and pull records in seconds during inspections. Complaint triage classifies incoming medical device complaints against FDA MDR and EU MDR reportability criteria. Each workflow is implemented with role-based access inheritance, read-only guardrails, full audit logging in TrackWise itself, and GAMP 5 Second Edition validation documentation that addresses AI-specific failure modes.
Safe AI access to GxP data requires multiple layers of control. First, AI agents authenticate as a dedicated Salesforce service user or inherit the requesting human user's Salesforce permissions via OAuth-based user context, so they cannot see anything the human cannot see. Second, the MCP adapter we build exposes only read-only operations and a curated tool set — no updates, no deletes, no metadata changes. Third, record-level filtering in the adapter can mask sensitive fields (e.g. pre-approval change controls during audit) based on context. Fourth, every AI query is logged in a dedicated audit trail that is inspectable alongside TrackWise's native field history and audit trail. Fifth, output validation checks verify AI responses are consistent with the underlying source data and flag potential hallucinations for human review. This approach aligns with both the FDA AI drug development guidance and the EMA reflection paper on AI in the lifecycle of medicines.
TrackWise Digital inherits native Salesforce AI capabilities — Einstein predictive models for lead/opportunity scoring patterns repurposed for event classification, and Agentforce for autonomous task execution. These are powerful and worth evaluating. The differences with an MCP-based approach: (1) MCP lets you bring best-in-class reasoning models (Claude Opus, GPT-5) rather than the specific models exposed through the Salesforce AI stack; (2) MCP adapters can aggregate data across TrackWise, LabWare, SAP, Snowflake, and external regulatory intelligence sources into a single agent context, while native Salesforce AI is stronger when the data is already inside Salesforce; (3) validation patterns are cleaner when the AI layer is architecturally separate from the system of record. IntuitionLabs helps pharma quality organizations evaluate native vs. MCP vs. hybrid architectures and implement whichever model best matches their quality and IT strategy.
Yes, and this is one of the highest-value AI use cases in pharmaceutical quality operations. Deviation investigations are time-consuming and typically require the investigator to pull context from TrackWise, LIMS (for analytical context), MES (for process context), SAP (for material and batch context), and historical CAPA records. An AI agent connected to all of these systems can pull the relevant context in seconds and draft a Phase 1 investigation summary that identifies potential root cause hypotheses, reviews similar historical events, and flags relevant CAPAs. The AI never closes an investigation or approves a decision — it drafts and cites, and humans decide. This approach aligns with FDA cGMP expectations for investigation rigor while dramatically compressing investigation cycle time, which directly improves FDA quality metrics reporting.
AI agents that access GxP-regulated quality data must be validated like any other GxP software component, with additional controls that address AI-specific risks. Our validation approach is aligned with GAMP 5 Second Edition, which explicitly addresses machine learning and AI: (1) risk-based classification under GAMP categories, typically Category 5 (custom application) for the MCP adapter and a context-specific approach for the underlying LLM; (2) intended use specification that defines what decisions the AI can and cannot influence; (3) prompt-engineering controls including version-controlled prompts, red-team testing, and prompt injection defenses; (4) output-validation test cases covering both factual accuracy and hallucination rates on a regulatory-relevant test set; (5) continuous monitoring in production with drift detection. See our dedicated TrackWise compliance and validation page for the full methodology.
Yes. Many of the highest-value AI workflows in pharma quality benefit from grounding in external regulatory intelligence — FDA 483 observations, warning letters, import alerts, recall databases, EMA inspection findings, and published guidance updates. We build MCP adapters that ingest sources like the FDA inspections database, warning letters, import alerts, and recall feeds, then agents can cross-reference internal TrackWise events against external regulatory patterns. This is particularly powerful for audit readiness: "show me our internal events related to the topics flagged in the last 12 months of FDA 483s for our product category."
Prompt injection and data leakage are first-order risks for any AI agent that touches GxP data, and we address them with defense-in-depth. Input controls: we sanitize and structure all inputs passed to the LLM, use structured prompts with clear delimiters, and never pass untrusted free-text directly into agent instructions. Permission scoping: the MCP adapter inherits the requesting user's Salesforce permissions, so even if a prompt injection succeeded in triggering a query, it could not exceed the user's authorized data access. Output controls: we validate AI responses against the underlying source data, flag citations that do not match the retrieved record, and block responses that attempt actions outside the read-only tool surface. Model choice: we prefer models with strong instruction-hierarchy training and we test against published prompt-injection benchmarks. Logging: every prompt, tool call, and response is logged in a tamper-evident audit trail. This aligns with NIST AI Risk Management Framework and emerging OWASP LLM Top 10 guidance.
A focused TrackWise AI integration project — a single use case like deviation triage or audit readiness — typically runs 10 to 16 weeks from kickoff through validated production, with costs in the $150K to $400K range depending on scope, validation depth, and integration breadth. A broader quality AI program covering multiple use cases across the TrackWise module suite, with integration to LIMS, MES, SAP, and Snowflake, is usually phased over 9 to 18 months. We structure engagements with a short discovery phase (4 to 6 weeks) that produces a detailed roadmap, business case, validation strategy, and specific use-case designs — so clients can make an informed decision about the broader program before committing. We are also happy to pilot a specific use case against a sandbox TrackWise Digital org to demonstrate value before production rollout.
Our default architecture is read-only, for good regulatory reasons — GxP data integrity expectations under MHRA guidance and FDA data integrity guidance require that every record change be attributable, contemporaneous, and approved. That said, there are well-scoped write patterns that can be safely enabled: an AI agent can draft a deviation record that a human reviews and commits; an AI can suggest a CAPA effectiveness verification plan that a quality professional approves; an AI can prepare an investigation summary for human sign-off. In all cases the human is the actor of record — the AI is an accelerator, not an approver. We design these patterns with specific Salesforce record-level controls, approval workflows, and AI-specific audit trail entries so that a regulator can understand exactly which decisions were AI-assisted.
Ready to Add AI to Your Quality Platform?
Ready to Add AI to Your Quality Platform? image

Ready to Add AI to Your Quality Platform?

Book a workshop to design your TrackWise Digital AI architecture, scope your first validated use case, and plan a phased rollout. From MCP adapter through GAMP 5 validation, we deliver production-grade AI for regulated pharmaceutical quality operations.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting